OTC:CSUI
CANNABIS SUISSE CORP.
A Swiss-focused cannabis developer with substantial lease liabilities awaiting regulatory milestones and commercial launch.
Key Metrics
Investment Thesis
Bull Case
Investors may view this as a high-risk, high-reward play on the emerging Swiss cannabis market where the company holds strategic lease positions ready for activation. If the team can successfully navigate regulatory hurdles and launch products, the current asset base could support rapid expansion once revenue streams materialize.
Bear Case
The stock is highly speculative given the absence of revenue for three consecutive years and a deeply negative shareholders' equity balance. The company's ability to service its debt and lease obligations without generating positive cash flow poses an existential threat that warrants extreme caution.
About CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a development-stage entity focused on the cannabis industry, specifically targeting the Swiss market with plans for cultivation and distribution. The company currently reports minimal operational revenue but maintains significant long-term assets related to operating leases. Key products are expected to include various cannabis derivatives intended for medical and recreational markets upon regulatory approval.
Analysis
Management Discussion
The company has struggled with significant cash burn, recording an operating cash flow of -$45.1M and a net loss of -$456k, while current liabilities exceed current assets by nearly $200k. Despite having substantial long-term lease assets, the entity lacks sufficient liquid capital to sustain operations without further capital raises or successful commercialization.
Industry Overview
The global cannabis industry is experiencing rapid growth driven by expanding legalization in North America, Europe, and parts of Asia, creating opportunities for specialized producers. The Swiss market represents a key emerging segment with strict regulations that offer barriers to entry but also significant long-term profit potential for compliant operators.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $10.0K | $30.0K | $22.5K |
| Cost of Revenue | $9.2K | $30.1K | $22.1K |
| Gross Profit | $834 | $-67 | $432 |
| Operating Expenses | $343.5K | $256.9K | $288.4K |
| Operating Income | $-342.7K | $-256.9K | $-288.0K |
| G&A | $60.7K | $174.7K | $228.7K |
| Stock-Based Comp | $124.0K | $20.0K | $0 |
| Depreciation | $4.2K | $4.2K | $4.2K |
| Other OpEx | $282.8K | $-109.9K | $-180.7K |
| Non-Operating Income | $-8.9K | $-1.0M | $-168.1K |
| Interest Expense | $8.9K | $26.8K | $63.2K |
| Pre-Tax Income | $-351.5K | $-1.3M | $-456.1K |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-351.5K | $-1.3M | $-456.1K |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-351.5K | $-1.3M | $-456.1K |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-351.5K | $-1.3M | $-456.1K |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $4.7K | $168.9K | $106.8K |
| Cash & Equivalents | $199 | $28.6K | $2.9K |
| Other Current Assets | $4.5K | $140.3K | $104.0K |
| Long-Term Assets | $341.6K | $649.7K | $528.2K |
| PP&E (Net) | $28.9K | $24.6K | $20.4K |
| Operating Leases | $312.7K | $625.1K | $507.9K |
| Other LT Assets | $0 | $0 | $0 |
| Total Assets | $346.3K | $818.6K | $635.1K |
| Current Liabilities | $333.8K | $381.0K | $325.5K |
| Accounts Payable | $10.8K | $4.3K | $7.8K |
| Current Leases | $150.0K | $125.2K | $105.1K |
| Other Current Liab | $164.2K | $251.5K | $212.6K |
| Long-Term Liabilities | $342.0K | $1.9M | $2.1M |
| Long-Term Debt | — | $424.6K | $610.7K |
| LT Operating Leases | $207.0K | $40.9K | $0 |
| Other LT Liab | $135.0K | $1.4M | $1.5M |
| Total Liabilities | $675.8K | $2.2M | $2.4M |
| Shareholders' Equity | $-329.4K | $-1.4M | $-1.8M |
| Paid-In Capital | $1.1M | $1.2M | $1.2M |
| Retained Earnings | $-1.4M | $-2.7M | $-3.1M |
| Total L&E | $346.3K | $818.6K | $635.1K |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-351.5K | $-1.3M | $-456.1K |
| Non-Cash Adjustments | $163.5K | $1.2M | $413.2K |
| Working Capital Changes | $24.1K | $2.0K | $-2.2K |
| Cash from Operations | $-164.0K | $-45.6K | $-45.1K |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $164.2K | $74.0K | $19.4K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $199 | $28.4K | $-25.7K |
| Beginning Cash | $0 | $199 | $28.6K |
| Ending Cash | $199 | $28.6K | $2.9K |
Frequently Asked Questions
How does CANNABIS SUISSE CORP. make money?
Cannabis cultivation and production, wholesale distribution of finished goods, and potential licensing or joint venture arrangements within the Swiss regulatory framework.
What are the main risks for CSUI?
Severe liquidity constraints evidenced by negative operating cash flow and a substantial retained earnings deficit; heavy reliance on external financing due to minimal current cash reserves; regulatory uncertainty in the Swiss cannabis market affecting time-to-revenue; high interest expense burden relative to limited revenue generation.
What is CSUI's competitive advantage?
Strategic positioning in the high-growth Swiss market with a dedicated focus on compliance and local partnerships; significant long-term asset base indicating preparedness for rapid scaling once operations commence.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.